Education
About Us
Working with TipRanks
Follow Us
Renascience Inc. (JP:4889)
:4889
Total Valuation
Renascience Inc. has a market cap or net worth of ¥22.93B. The enterprise value is ¥21.37B.
Market Cap¥22.93B
Enterprise Value¥21.37B
Share Statistics
Renascience Inc. has 12,711,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,711,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Renascience Inc.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -8.20%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)-8.20%
Return on Capital Employed (ROCE)-0.10
Revenue Per Employee33.17M
Profits Per Employee28.36M
Employee Count4
Asset Turnover0.07
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Renascience Inc. is 361.2. Renascience Inc.’s PEG ratio is ―.
PE Ratio361.2
PS Ratio―
PB Ratio―
Price to Fair Value7.74
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Renascience Inc. had revenue of 132.69M and earned 113.43M in profits. Earnings per share was 8.92.
Revenue132.69M
Gross Profit128.95M
Operating Income-178.83M
Pretax Income143.76M
Net Income113.43M
EBITDA143.82M
Earnings Per Share (EPS)8.92
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Renascience Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change432.15%
50-Day Moving Average2.45K
200-Day Moving Average1.53K
Relative Strength Index (RSI)33.29
Average Volume (3m)626.68K
Important Dates
Renascience Inc. upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Renascience Inc. as a current ratio of 12.38, with Debt / Equity ratio of 0.00%
Current Ratio12.38
Quick Ratio12.38
Debt to Market Cap0.00
Net Debt to EBITDA-12.51
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Renascience Inc. has paid 30.34M in taxes.
Income Tax30.34M
Effective Tax Rate0.21
Enterprise Valuation
Renascience Inc. EV to EBITDA ratio is 80.11, with an EV/FCF ratio of -65.04.
EV to Sales86.83
EV to EBITDA80.11
EV to Free Cash Flow-65.04
EV to Operating Cash Flow-65.34
Balance Sheet
Renascience Inc. has ¥1.80B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of ¥1.80B billion.
Cash & Marketable Securities¥1.80B
Total Debt¥0.00
Net Cash¥1.80B
Net Cash Per Share¥141.59
Tangible Book Value Per Share¥135.32
Margins
Gross margin is 96.94%, with operating margin of -134.77%, and net profit margin of 85.48%.
Gross Margin96.94%
Operating Margin-134.77%
Pretax Margin108.34%
Net Profit Margin85.48%
EBITDA Margin108.39%
EBIT Margin108.34%
Analyst Forecast
The average price target for Renascience Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-27.00%
EPS Growth Forecast―